If you have patients that meet the following criteria, they may be eligible for the VISTAS clinical study:
PSC is a rare liver disease that causes damage to the bile ducts outside and sometimes inside the liver. It is frequently associated with inflammatory bowel disease (IBD). While PSC affects mostly men, women can also develop this condition. A common complication from PSC is itching which can lead to fatigue, social isolation, and an overall lower quality of life. Currently there are no approved or effective medications to treat PSC or PSC-associated itch, and some patients ultimately require liver transplantation. Sometimes the itch itself can be an indication for liver transplantation.
Mirum is committed to putting the needs of patients first. We’re transforming lives devastated by rare liver disease through the development and delivery of therapies that address the urgent unmet need and fill a therapeutic void. Through continued clinical evaluation of our investigational therapies, we’re fulfilling our promise to the community.
Left untreated, these diseases can lead to liver failure, liver transplant, and a host of life-altering symptoms that can profoundly impact the quality of life for patients and their families. Some patients may need a liver transplant and are at high risk for many other serious health issues.
For more information about Mirum Pharmaceuticals, visit us at www.mirumpharma.com.